ClinicalTrials.Veeva

Menu

Type 1 Diabetes Education and Support Study (T1DES)

Kaiser Permanente logo

Kaiser Permanente

Status

Active, not recruiting

Conditions

Type1diabetes

Treatments

Behavioral: Diabetes Education
Behavioral: T1DES

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05735340
1R01DK128236-01A1 (U.S. NIH Grant/Contract)
RNG211852

Details and patient eligibility

About

Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailored intervention T1DES and evaluates the effect of the T1DES intervention on diabetes outcomes in a pilot randomized clinical trial among Black young adults with T1D.

Full description

This research focuses on the unique needs of Black young adults aged 18-30 years to address a critical gap in the research and clinical care. The goal is to test the feasibility and preliminary efficacy of a culturally adapted and tailored intervention to enhance diabetes management strategies among Black young adults with T1D, addressing the pervasive racial disparity in health outcomes for this population.

The specific aims for this study are to:

Aim 1: Assess feasibility of the culturally tailored intervention T1DES by measuring intervention acceptability, demand (retention, completed > 80% of sessions), practicality, and implementation fidelity through participant surveys and key informant interviews with participants and the health care delivery team.

Aim 2: Evaluate the effect of the T1DES intervention on diabetes outcomes in a pilot randomized clinical trial among N=40 Black young adults age 18-30 years with T1D and elevated HbA1c (>7.5%) by comparing changes in HbA1c, diabetes distress, and self-management from baseline to 6-months post-baseline among participants randomized to T1DES compared to the diabetes education-only control condition.

The goal of this study is to provide diabetes education and emotion regulation support tailored for Black young adults' experiences that will result in sustained glycemic control and can be incorporated into adult endocrinology practices.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Kaiser Permanente Georgia Member
  • Aged 18 - 30 years
  • Confirmed diagnosis of Type 1 diabetes
  • Hemoglobin A1c > 7.5 at time of enrollment
  • a cell phone able to send/receive text messages
  • Self-reported race of Black or African American
  • Ability to read in English and provide informed consent

Exclusion criteria

  • Developmental delay or other cognitive impairment that would render the participant unable to provide informed consent
  • Subjects with visual impairment or have severe hearing or other physical disabilities that would be a barrier for participating in-group or web sessions
  • Diabetes complications that would preclude participation in the study

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Diabetes Education
Active Comparator group
Description:
Participants in this arm will receive traditional diabetes education following a baseline assessment. During months 1-3, participants will attend 5 sessions. Follow-up will be conducted at 3-months and 6-months.
Treatment:
Behavioral: Diabetes Education
T1DES
Experimental group
Description:
Participants in this arm will receive a emotion regulation intervention called T1DES following a baseline assessment. During months 1-3, participants will attend 5 sessions. Follow-up will be conducted at 3-months and 6-months.
Treatment:
Behavioral: T1DES

Trial contacts and locations

1

Loading...

Central trial contact

Teaniese L Davis, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems